drugset / Trial / NCT04457011

Efficacy and Safety of Susu Zhike Granules for Treating Acute Cough Due to Common Cold With Cold-cough Syndrome in Children

NCT04457011 ↗

Phase 2 Completed 240 enrolled Tasly Pharmaceutical Group Co., Ltd
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This protocol is designed with the aim of exploring the efficacy of Susu on shortening duration and reducing severity of cough, and observe the safety used in children.

Timeline

Start
2020-09-19
Primary completion
2022-02-24
Completion
2022-02-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Susu Xiao'er Zhike Granules Traditional medicine (herbal / TCM) 1.01 g —
Subject Susu Xiao'er Zhike Granules Traditional medicine (herbal / TCM) 10.12 g —
Subject Susu Xiao'er Zhike Granules Traditional medicine (herbal / TCM) 20.25 g —

Indications

No indication recorded.